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Abstract 
Linaridins are rare linear ribosomally-synthesized and post-translationally modified peptides (RiPPs) and only 
two, cypemycin and SGR-1832, in this family have been identified so far. Legonaridin 1 has been discovered as 
a new member of linaridins through chemical isolation, peptidogenomics, comprehensive 1- and 2-D NMR and 
advanced Marfey’s analyses from the soil bacterium Streptomyces sp. CT34, an isolate collected from Legon, 
Ghana. Bioinformatics analysis of the gene cluster suggested that the biosynthesis of legonaridin 1 is different 
from the ones for cypemycin and SGR-1832. Consistent with bioinformatics and peptidogenomics analyses, 1 
has a total of nine post-modifications, 8 dehydrobutyrine residues and N,N-dimethylated N-terminus with a 
carboxylic acid at the C-terminus. Legonaridin 1 is structurally different from the two known linaridins 
comprising a new subfamily. This is the first time to use NMR spectroscopy to establish the 2-D structure of a 
linaridin RiPP. 
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Introduction  
There is an increasing interest in the discovery of new ribosomally-synthesized and post-translationally 
modified peptides (RiPPs).
1
 RiPPs are a major class of natural products that has only been recently discovered 
and found in all three domains of life.
2
 Although these molecules explore only the 20 proteinogenic amino 
acids, extensive posttranslational modifications provide these peptide with enormous chemical and biological 
diversity.
3
  
The structural complexity of RiPPs taken together with their often high molecular weight has made their 
chemical discovery extremely time-consuming.
4
 This is exemplified for the discovery of the polytheonamides 
which were reported in 1994 as cytotoxic constituents of the Japanese sponge Theonella swinhoei, which 
harbours a large diversity of symbiotic bacteria.
5
 It took more than 10 years for the same research group to 
establish the precise structure of these compounds as highly complex 48-mer peptides.
6
 
Linaridins are rare RiPPs.
7
 Despite increased numbers of RiPPs discovered, only two linaridins have been found 
so far including cypemycin, the founding member of linaridin family 
7
 and grisemycin (SGR-1832) 
8
 (Figure 1). 
Both linaridins possess common structural features, notably AviCys moiety in C-terminus, N, N-dimethylalanine 
at N terminus and dehydrothreonine moieties.
7,8
  
 
Figure 1. Cypemycin is the founding member of the linadrinin family from Streptomyces sp. OH-4156. 
Grisemycin (SGR-1832) is the second linadrinin identified from Streptomyces griseus IFO 13350. Both 
compounds contain an N-terminal N,N-dimethylalanine, a C-terminal aminovinyl-cysteine (AviCys) ring and 
dehydrated threonines (X or dehydrobutyrines). Cypemycin also possesses two L-allo-isoleucine residues. The 
stereochemistry of isoleucine residues in SGR-1832 has not been established. The red colour represents the 
posttranslationally modified amino acid residues.
 
 
During the course of our investigation on biodiversity in Ghana, we were able to isolate several new soil 
actinomycetes including Streptomyces sp. MA37 
9
 and two new mangrove strains, Micromonospora sp. K310 
that produces butremycin, a new derivative of ikarugamycin,
10
 and Verrucosispora sp. K51G, the producer of a 
new pyrazinone butrepyrazinone.
11
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Here we report the discovery and characterization of a new linaridin, legonaridin 1, using a combination of 
chemical isolation, peptidogenomics, and comprehensive NMR spectroscopic analysis, from Streptomyces sp. 
CT34 (Figure 2). The identity of the gene cluster directing the biosynthesis of 1 was confirmed through gene 
inactivation. The absolute structure of 1 was established through advancedMarfey’s analysis, suggesting that 1 
is structurally different to cypemycin and grisemycin, and belongs to a new subgroup of linaridin RiPP family, 
consistent with our bioinformatics analysis. 
Results and discussion 
Identification of peptide from Streptomyces sp. CT34 
Streptomyces sp. CT34 is a new Streptomyces strain that was isolated from a rhizosphere sample from Legon, 
Ghana (Figure S1). Metabolite profiling of the strain revealed the presence of a high molecular-weight 
metabolite (3600.8 Da) only under the acidic culturing condition (pH 5.5). Large scale fermentation, extraction 
and solvent partitioning using modified Kupchan method,
12
 followed by RP-HPLC of the CH2Cl2 fraction allowed 
the isolation of pure compound 1 (9 mg).  
Analysis of high resolution electrospray ionization mass spectrometry (HR-ESIMS) gave monoisotopic ion [M + 
4H
+
]
4+
 at m/z of 901.2230 (Figure 2A). Inspection of 
1
H NMR indicated the presence of a group of α-H signals 
around 4.5 ppm, suggesting that 1 is a peptidic natural product (Figure S2). The rest of proton signals were, 
however, heavily overlapped, which would have prevented full structural characterization. For this reason a 
different approach was needed to fully establish the structure of legonaridin 1. 
 
 
Figure 2. (A). Mass spectrometric identification of the 3600 Da legonaridin 1 from the organic extract of 
Streptomyces sp. CT34 (ion [M+4H]
4+
); (B) Generation of 7 reverse sequence tags from the purified legonaridin 
1 by FTICR-mass spectrometric detection. X = dehydrobutyrine and Z = unidentified amino acid residue. 
 
We then applied the peptidogenomics methodology 
8
 developed by one of our authors (PCD) and generated 7 
identifiable peptide fragments (Figure 2B).
 
This was obtained by using tandem MS (MS
n
) fragments to generate 
sequence tags for this peptide which was then subjected to collision-induced dissociation (CID) fragmentation 
4 
 
and the sequential fragment ions were assigned through de novo analysis of MS
n
 spectra (Figure S3-4). Almost 
all of the mass shifts generated can be substituted with proteinogenic amino acids except mass shifts of 83 Da 
which were assigned to the non-proteinogenic amino acid dehydrobutyrine (X or Dhb). Interestingly, serine 
residue(s) in the sequence tags remained intact. A similar feature was also observed in the RiPP natural 
products such as lantibiotics and other linaridins in which serine residues are less favoured than threonine 
residues for dehydration.
13
 This suggested that this compound may be a ribosomally-derived peptide. 
Identification of the peptide sequence 
Illumina-based genome scanning of Streptomyces sp. CT34 was carried out, generating 8.05 Mbp of sequence 
with 310 contigs, and the draft genome was deposited in NCBI database.
14 
The sequence was annotated using 
the AntiSMASH software.
15 
Through peptidogenomics-based matching, we found one putative peptide, LegA, 
that was annotated as a homolog of the precursor peptide CypA of cypemycin. In comparison with the mature 
peptides of cypemycin and grisemycin, we proposed that the mature peptide of 1 started with isoleucine (Ile) 
and have 37 amino acids in total (Figure 3A and B), indicating that 1 is a new member of the emerging linaridin 
RiPP family, which we named legonaridin after its association with Legon, Ghana, the location of the University 
of Ghana. 
Analysis of the surrounding genetic environment of legA allowed identification of a candidate gene cluster 
(leg) (Figure 3A and Table S1). Gene inactivation of the entire cluster completely abolished the production of 1, 
indicating that the leg cluster indeed directs the biosynthesis of 1. The leg cluster possesses 8 ORFs, 2 of which, 
LegD and F, share moderate sequence identities with CypM (30%) and CypL (37%), respectively, in the 
cypemycin pathway (Table S1). Biochemical assay demonstrated that CypM is responsible for the N,N 
dimethylation of the N-terminal Ala in the biosynthesis of cypemycin,
7
 an unusual peptide modification that 
was also observed in SGR-1832 linaridin peptide.
8
 Therefore, it is proposed that LegD may generate N-
methylation on the N-terminus Ile of 1. The two genes, legE and legH, encode Alpha/beta(Ab) hydrolase fold 
protein and HTT membrane protein, in the close proximity of legA, respectively (Figure 3A). Interestingly, LegE 
has moderate sequence identity (31% identity) with the hydrolase domain of CypH whereas LegH has 
moderate sequence identity (40% identity) with the HTT domain of CypH (Table S1). It appears that the cypH 
homolog in the leg cluster is split into two individual genes. The presence of both encoded CypL and CypH are 
required for the production of cypemycin. CypL and/or CypH are believed to catalyze the dehydration of 
threonine residues into the mature peptide.
7
 The presence of genes legE, F, and H in the leg cluster suggests 
that these gene products may be required for the production of 1, possibly playing the same roles as CypL and 
H in the maturation of cypemycin. However, one cannot exclude the possibility that LegC, a putative FAD-
dependent oxidoreductase, may catalyse the dehydration of all of Thr residues. The exact in vivo roles of these 
four genes remain to be determined. In the cypemycin biosynthesis, CypD is responsible for the 
decarboxylation of the cysteine residue in the C-terminus, the essential biosynthetic step to construct the 
AviCys motif.
7 
The cypD homolog gene was also observed in the SGR-1832 cluster.
8
 However, there is no cypD 
homolog gene in the leg cluster in the CT34 strain, suggesting that legonaridin is a completely linear peptide 
with a free carboxylic acid group at the C-terminus. Interestingly, the presence of cypD homolog genes is not 
5 
 
common in the putative linaridin clusters and was only observed in the cypemycin and SGR-1832 clusters.
7,8 
Moreover, no CypI homolog gene was observed in the close proximity of leg cluster. CypI was proposed to 
epimerize L-isoleucine residue to L-allo-isoleucine.
7 
Therefore, it is likely that the L-configuration of the two 
isoleucine residues in the legonaridin 1 has been retained.  
 
Figure 3. (A) Schematic representation of the biosynthetic gene clusters of linaridin RiPPs. The sequence tags 
generated by MSn from legonaridin 1 are highlighted in Red. (B) The sequence alignment of legonaridin 
precursor peptide sequence and cypemycin and grisemycin (SGR-1832) precursor peptide sequences. The red 
arrow indicates the possible first amino acid in the matured legonaridin. 
NMR analysis confirms that 1 is a new linaridin RiPP 
In silico analysis allow us to propose the structure of 1 as shown in Figure 4, which was corroborated by MS
n
 
fragments, providing strong supportive evidence that the predicted structure is correct. The molecular formula 
of 1 was established as C165H254N45O44S based on the HR-ESIMS analysis (observed [M + 4H
+
]
4+
 = 901.2230, 
calculated [M + 4H
+
]
4+
 = 901.2238, Δ = 5.042 ppm. We then revisited the NMR experiments including 
1
H, COSY, 
TOCSY, HSQC, HMBC and NOESY (Table 1 and Figures S2, 5-9). Despite of overlapping peaks, all protons were 
successfully assigned through a strategy based on definition of the amino acid spin systems 
16-18
 by inspection 
of COSY and TOCSY NMR data, followed by confirmation of the overall amino acid sequence using NOESY data 
(Figure 5). The most predominant NOE correlations were those of N(i)-N(i+1) and Hα(i)-N (i+1) and were strong to 
medium between all neighbouring residues with the exception of X2-P3, X9-P10, X13-P14 and F17-A18 (Figure 
5). The latter of the four pairs proved difficult to determine as the amide protons of F17 and A18 shared a 
similar 
1
H shift (8.28 ppm and 8.29 ppm respectively) (Figure 5). A weak NOE correlation was however 
observed between 7.23 ppm (F17δ) to 8.29 ppm and 1.62 ppm (A18β), suggesting the F17-A18 sequence 
(Figure 5). 
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Figure 4. Structural elucidation demonstrated that 1 is a new class of linaridin family that the C-terminal is 
unmodified. The post-translational modifications of amino acids residues has been highlighted in red. 
NOE correlations between Hδ in proline and the neighbouring H in N-atom finally confirmed the sequences of 
X2-P3, X9-P10 and X13-P14 linkages, as illustrated in Figure 4. Many of the 
13
C could also be assigned, and in 
some cases inter residue connectivity could be corroborated using HMBC correlations. Using the advanced 
Marfey’s analysis,
19
 we confirmed that the absolute configuration of the unmodified amino acid residues is L-
configuration, consistent with the above bioinformatics analysis. When tested for various antibacterial and 
cytotoxic activities, 1 displayed weak activity. The exact biological role of this peptide remains undefined. 
 
 
Figure 5. NOE correlations of legonaridin 1 confirming the sequence of the amino acid residues. X = Dhb 
residue. 
Table 1. NMR spectroscopic data (600 MHz, CD3OH, 298K) for legonaridin 1 
Residue C HN Cα Hα Cβ Hβ Cγ Hγ Others 
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I1 175.9 N/A 73.1 3.85 34.7 2.14 24.1 1.21, 1.59 Cδ/ Hδ 11.3/0.96, NMe2 
42.1/2.94 
            15.2 1.17   
X2 168.4 10.27 130.7 N/A 124.0 5.95 12.2 1.85   
P3 nk N/A 62.4 4.41 30.7 2.01, 2.36 25.6 1.99 Cδ/ Hδ 51.4/3.69, 3.88 
L4 168.7 8.13 53.5 4.38 40.1 1.71, 1.75 25.6 1.71 Cδ/ Hδ 23.2/0.98 
                Cδ/ Hδ 21.1/0.92 
A5 178.0 8.11 51.6 4.17 16.9 1.48 N/A N/A   
X6 167.2 9.22 130.7 N/A 130.7 6.52 12.3 1.78   
L7 nk 7.80 54.2 4.35 40.6 1.65, 1.79 25.6 1.77 Cδ/ Hδ 23.5/0.99 
         Cδ/ Hδ 21.4/0.93 
A8 174.4 8.02 50.6 4.53 17.4 1.52 N/A N/A   
X9 168.7 9.26 131.9 N/A 124.9 5.91 12.2 1.79   
P10 nk N/A 63.4 4.34 30.4 1.92, 2.40 26.1 2.08, 1.92 Cδ/ Hδ 50.2/3.58, 3.65 
E11 175.1 7.95 63.4 4.33 26.7 2.21 31.4 2.49  Cδ 175.9 
A12 175.5 8.01 52.1 4.28 17.1 1.43 N/A N/A   
X13 169.3 9.36 131.9 N/A 124.7 5.80 12.2 1.84   
P14 nk N/A 63.9 4.38 30.9 1.97, 2.47 26.1 2.17, 1.95  Cδ/ Hδ 50.3/3.52, 3.70 
V15 175.6 7.70 64.4 3.79 30.0 2.29 20.6 1.13   
      19.3 1.02   
G16 166.3 8.07 45.4 3.84 N/A N/A N/A N/A   
F17 176.1 8.28 59.0 4.28 37.2 3.20, 3.16 N/A N/A C1 - 137.4 
        C2,6 - 129.7 / 7.23 
        C3,5 - 127.6 / 7.20 
        C4 - 129.1 / 7.26 
A18 177.5 8.29 53.6 4.11 16.2 1.62 N/A N/A   
A19 177.1 8.52 53.6 4.19 16.2 1.63 N/A N/A   
X20 167.7 9.33 130.2 N/A 129.9 6.37 12.6 1.76   
S21 174.2 7.96 59.9 4.27 61.7 3.97, 3.85 N/A N/A   
A22 178.0 8.17 53.9 4.11 15.8 1.47 N/A N/A   
X23 167.7 9.39 130.8 N/A 128.8 6.28 12.2 1.72   
A24 177.8 8.04 53.6 4.10 16.0 1.56 N/A N/A   
A25 177.8 8.01 53.5 4.20 16.0 1.57 N/A N/A   
A26 177.3 8.15 53.6 4.22 16.2 1.63 N/A N/A   
V27 177.4 8.36 65.4 3.63 30.0 2.25 17.0 1.18   
      19.4 0.99   
N28 173.5/176.6 8.34 55.0 4.44 37.3 2.85, 2.92 173.5/176.6 N/A γNH2 - 7.02, 7.21 
M29 174.4 8.16 57.7 4.24 31.1 2.54 50.4 3.21 εCH3 – 38.0 / 2.65 
I30 175.9 8.45 64.3 3.98 36.3 2.20 26.4 1.29, 1.64 Cδ/ Hδ 11.1/0.98 
      16.9 1.18   
X31 168.2 9.84 131.3 N/A 129.6 6.29 12.5 1.77   
H32 nk 7.78 56.6 4.47 26.6 3.24, 3.40 N/A N/A C1 131.07 
        C2 - / 7.51 
        C3 135.0 / 8.76 
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D33 nk 8.25 nk 4.70 35.6 3.05, 3.15 nk N/A   
V34 175.9 8.21 63.2 3.91 30.4 2.22 19.5 1.08   
      19.4 1.04   
X35 166.3 9.06 130.3 N/A 133.4 6.72 13.0 1.8   
R36 nk 7.48 55.2 4.29 29.3 1.85 26.4 1.65 Cδ/ Hδ 50.5/3.20,   Cε 
158.4 
               Nε 7.37 
H37 172.8 8.39 52.4 4.79 27.5 3.18, 3.35 N/A N/A C1 130.7 
        C2  118.6/ 7.40 
                C3 134.7 / 8.79 
n/k = not known, not found    n/a = not applicable 
 
Database mining suggests that 1 belongs to a new subgroup of linaridin RiPPs 
A homolog search of the precursor peptide LegA in the public domain indicated that LegA also share high 
sequence identity (60%-70% AA identity) with five hypothetic proteins in other Streptomyces strains (Figure 
S10), which offers six gene clusters to compare and contrast their immediate environment. These five putative 
gene clusters possess striking similarity to the leg cluster. So far the genes encoding methyltransferases and 
CypL homolog proteins are highly conserved in the clusters of cypemycin, grisemycin, legonaridin and these 
five putative linaridins. ABC transporter, FAD-dependent oxidoreductase, Alpha/beta(Ab) hydrolase fold 
protein and HTT membrane protein are unique to the ones of legonaridin and the five putative linaridins. No 
cypI and cypD homologs can be identified in these five new putative clusters and the leg cluster. Phylogenetic 
analysis suggested that these five new putative precursor peptides and LegA form a distinct branch with the 
ones of cypemycin and grisemycin (Figure S11). Taken together, we proposed that legonaridin 1 should be a 
new subgroup of linaridin RiPPs.  
Conclusions 
In conclusion, legonaridin 1, a new member of linaridin RiPP was discovered from the soil bacterium 
Streptomyces sp. CT34 through metabolite profiling and chemical isolation. MS
n
-guided genome mining 
approach allowed identification of the precursor peptide of legonaridin and the putative leg gene cluster 
responsible for the biosynthesis of legonaridin. The absolute structure of legonaridin 1 was established 
through peptidogenomics, genomic-driven analysis, extensive spectroscopic analysis, and advancedMarfey’s 
analysis revealed that 1 is a 37-mer linear peptide with some unusual chemical modification, including an N-
terminal N,N-dimethylalanine and dehydrothreonine moieties. Despite of the same chemical features in 1 as 
the ones observed in cypemycin and grisemycin, legonaridin 1 has a structurally different C-terminus with a 
free carboxylic acid, suggesting that 1 forms a new subgroup of the rare linaridin RiPP family, in line with our 
bioinformatics analysis. 
Experimental Section 
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General information 
NMR data were acquired on a Varian NMR spectrometer operating at 600 MHz for proton and 150 MHz for 
carbon. High resolution mass spectrometric data were obtained using a Thermo Instruments MS system (LTQ 
XL/LTQ Orbitrap Discovery) coupled to a Thermo Instruments HPLC system (Accela PDA detector, Accela PDA 
autosampler and Accela pump). The following conditions were used: capillary voltage 45V, capillary 
temperature 260 
o
C, auxillary gas flow rate 10-20 arbitrary units, sheath gas flow rate 40-50 arbitrary units, 
spray voltage 4.5 kV, mass range 100-2000 amu (maximum resolution 30,000). HPLC separations were carried 
out using a Phenomenex Luna reversed-phase (C18 250 × 10mm, L × i.d.) column connected to a Waters 1525 
Binary HPLC pump Chromatograph with a 2998 PDA detector, column heater and in-line degasser. Detection 
was achieved on-line through a scan of wavelengths from 200-400 nm. The optical rotation was measured 
using Bellingham+Stanley 37-410 polarimeter, UK. The UV spectrum was acquired using Agilent Cary 60 UV-Vis 
spectrometer, UK. The IR spectrum was measured using Perkin Elmer FT-IR spectrometer Ultra Two, UK. Diaion 
HP-20 was obtained from Resindion S.R.L., a subsidiary of Mitsubishi Chemical Co., Binasco, Italy. All solvents 
used throughout were HPLC-grade and purchased from Sigma-Aldrich (Germany) through a Ghana based agent 
(Huge Limited). Sephadex LH-20 (25-100μm) was purchased from GE Healthcare (Little Chalfont, UK).  
Plasmids and bacterial strains are summarized in Table S2. Restriction enzymes were purchased from New 
England Biolabs and chemicals from Sigma-Aldrich. Oligonucleotide primers (Table S2) were purchased from 
Sangon Biotech.  
Isolation of Streptomyces sp. CT34 
The rhizosphere sample was obtained near a Caesalpinoideae tree (Tamarindus Indica, Africa) in the Botanic 
Garden in the University of Ghana, Legon (5
o
39’32.72” N, 0
o
11’55.26” W). Streptomyces sp. CT34 was isolated 
using the procedure outlined as follows: the soil sample was suspended in sterile water. The suspension was 
transferred to modified ISP2 agar plates (oxoid agar, 15g; glucose, 4g; yeast extract, 4g; malt extract, 10g; pH 
5.5) supplemented with nalidixic acid (25 μg/mL) and nystatin (25 μg/mL) and incubated at 28 
o
C for 7 days. 
The pure strain was obtained after repeatedly transferred and streaked on different fresh ISP2 agar plates. 
Cultivation of Streptomyces sp. CT34 
The pure strain was maintained on ISP2 agar plates at 28 
o
C. For seed culture, Streptomyces sp. CT34 spores 
were inoculated into modified ISP2 liquid medium (50 mL, pH 5.5) in an Erlenmeyer flask (250 mL) and 
cultivated in a rotary incubator (180 rpm, Barnstead Lab-line MaxQ 5000) at 30 
o
C for 5 days. For the large 
scale fermentation, the seed culture was transformed to modified ISP2 (pH 5.5) (4 litres), containing glucose 
(4g/L), yeast extract (4g/L) and malt extract (10g/L). Diaion HP-20 (50g/L) was also added during the 
fermentation.  
 
Extraction and Isolation 
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After 7-day fermentation, HP-20 resin was filtered under the reduced pressure. HP-20 resin was washed with 
distilled water, and then extracted with methanol (3x500 mL). The successive MeOH extracts were combined 
and concentrated under reduced pressure, followed solvent partition using the modified Kupchan method. 
The dichloromethane (CH2Cl2) fraction was subjected to semi-preparative reversed-phase HPLC (C18 Sunfire™ 
250×10 mm Waters; A: water, B: Methanol; gradient 0-40 min 60-100% B; flow rate 1.5 mL/min) to afford 9 mg 
of pure 1.  
Compound 1: white powder; [α]D
25
 -1.1 (c 0.06 in MeOH); UV (MeOH) λmax (log ε) 281 (4.20) 213 (4.20) nm; IR 
(film) νmax 3416, 2978, 1647, 1453, 1383, 1087 cm
-1
; 
1
H, HSQC, COSY, TOCSY, HMBC and ROESY NMR data see 
Table 1; HRESIMS m/z 901.223 [M + 4H]
4+ 
Δ 5.042 ppm calculated for as C165H254N45O44S. 
De novo MS/MS for identification of sequence tags.  
Data were acquired on a Thermo LTQ-FT 7T instrument using an Advion Nanomate nanoelectrospray infusion 
robot. The sample was diluted in 50/50 acetonitrile water with 0.1% formic acid.  Samples were infused at 
approximately 200 nL/min with an applied voltage of 1.8 kV.  Gas settings were all set to 0 with an inlet 
temperature of 250 
o
C. The instrument was manually controlled during acquisition and MS parent ion spectra 
were collected from 150-2,000 m/z in profile mode as analyzed in the FTMS cell. MS
2 
and
 
MS
3
 spectra were 
collected at varying collision energies, isolation windows, and acquisition windows optimized for optimal signal 
and isolation efficiency.  Acquired spectra were manually interpreted.  High-resolution, but lower signal to 
noise FT spectra were compared against low-resolution but higher signal to noise iontrap spectra.  FT peaks 
without isotopes and absent from the iontrap spectra were identified as electronic noise. FT transients of were 
collected at 128-256k.  All spectra analyzed were averaged (18-356). 
Genome sequence  
The genome sequence of CT34 was deposited in GenBank under the accession no: JSFP00000000.
14
 The 
legonaridin biosynthetic gene cluster was identified using seven sequence tags generated by MS
n
 
fragmentation as the sequence query.  
The open reading frames (ORFs) were deduced from the sequence by performing FramePlot 4.0 beta program 
(http://nocardia.nih.go.jp/fp4/). The corresponding deduced proteins were compared with other known 
proteins in the databases using the Basic Local Alignment Search Tool (BLAST) 
(http://www.ncbi.nlm.nih.gov/blast/). Amino acid sequence alignments were performed with the CLUSTALW 
algorithm from BIOLOGYWORKBENCH 3.2 software (http://workbench.sdsc.edu).  
Advanced Marfey’s method 
A 0.5 mg quantity of Legonaridin 1 was hydrolyzed in 0.3 mL of 6 N HCl at 115 
o
C for 6 h; the reaction was then 
cooled rapidly by placing the reaction vial into ice water for 3 min. The reaction solvent was evaporated in 
vacuo, and residual HCl was completely removed by adding 0.5 mL of H2O and removing the solvent three 
times. The dried hydrolysate was lyophilized for 24 h. The hydrolysate containing the free amino acids was 
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divided into two portions, and each portion was transferred into a 10 mL vial. The hydrolysate was then 
dissolved in 50 μL of 1 N NaHCO3. To each of the two vials containing the dissolved free amino acids, 50 μL of 
either 10 mg/mL L-FDLA (1-fluoro-2,4-dinitrophenyl-5-L-leucine amide) or D-FDLA (1-fluoro-2,4-dinitrophenyl-
5-D-leucine amide) in acetone was added. The reaction mixtures were incubated at 50 
o
C for 30 min. A 50 μL 
aliquot of 2 N HCl was added to neutralize the reaction, followed by the addition of 300 μL of aqueous 50% 
CH3CN. A 10 μL aliquot of each reaction mixture was analysed by LC-MS with a gradient solvent system (20% to 
100% CH3CN containing 0.1% formic acid over 40 min, C18 reversed-phase column 100 × 4.6 mm). L-FDAA 
derivatives eluted before D-FDAA derivatives for all amino acid residues in the hydrolysate. Therefore, the 
absolute configurations of the unmodified amino acid residues in 1 were determined as L. 
Generation of Knockout Constructs  
To delete the leg gene cluster, a 1880 bp upstream fragment and a 1990 bp downstream fragment were 
amplified from genomic DNA of Streptomyces sp. CT34 by PCR using the primers U1/U2 and D1/D2, 
respectively (Table S2). The PCR products were purified using the Omega PCR purification kit and were cloned 
in pUC-T simple vector to generate constructs, pWHU2261 and pWHU2262 (Table S2). After sequencing 
verification, the fragments were digested by NdeI/XhoI and XhoI/HindIII from pWHU2261 and pWHU2262 
respectively. The obtained fragments were cloned into the NdeI and HindIII site of pYH7 to fulfil the in-frame 
deletion construct pWHU2263 which was then transferred into CT34 strain via E. coli-Streptomyces 
conjugation.
20
 A PCR-based screening allowed identification of the in-frame deletion mutant M-ZY using two 
PCR primer pairs of L1/L2 and R1/R2 (table S2).  
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